Pulmonary Hypertension (PH/PAH)

  2. Home
  3. Education
  4. Top Disease Areas
  5. Pulmonary Hypertension (PH/PAH)
  6. Specialty Area
  7. Nurse Practitioner
Page 2 of 6
Results 76 - 150 of 384
9165 pneumo explore
Utilizing ACIP's Updated Pneumococcal Recommendations
9152-sma-explore
Updates in Spinal Muscular Atrophy: An EXPLORE Learning Experience
9165 product
Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap
Image20220927093935
Growing Importance of Newborn Screening in DMD
Image20220927093938
The Immune Response in DMD Gene Therapies
Image20220927093921
New Data from Gene Therapy Clinical Trials in DMD
Image20220927093941
Changing the Phenotype of DMD
9078_DMD-icon9
DMD and Gene Therapy: What's on the Horizon?
9155-cart-cell
CAR T-Cell Therapy Consults: Navigating a New Landscape
9167-0001-263x149
Treating Persistent/Chronic ITP: Current Care, Future Potential
Am I Treating My Patients With Psoriatic Disease Effectively?
Am I Treating My Patients with Psoriatic Disease Effectively?
No image set
Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)
9166-covid
Reducing the Risk of Severe Illness for Patients With COVID-19
No image set
Emerging Treatments in Chronic GvHD
No image set
Treatment of Ph+ Relapsed/Refractory ALL
No image set
Treatment of Ph- Relapsed/Refractory ALL
9157-mod2
Treating Complex Cases of NTM-LD
9157-mod1
NTM-LD Diagnosis and Management
9157-0003-slide263x149
NTM-LD Daignosis and Management - Slide Deck
9143 Thumb
Emerging Nonfactor Approaches for Patients with Hemophilia
No image set
Identification of Relapsed ALL
No image set
ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19
9089_nsclc_titleslide
TARGET for NSCLC: Genomic Pathways and Use of EGFR Therapies
No image set
PAH: Risk Reduction Strategies Using Single and Combination Therapies
No image set
Ensuring Effective Care Transitions in Beta Thalassemia
9102-chest-slides
IPF Management and Antifibrotic Therapy - Slide Deck
9088-covid-slides
Post COVID-19 and Patients With and Without Pre-existing ILD - Slide Deck
9088-ipf-slides
A Collaborative Approach to IPF Management - Slide Deck
9088-sscild-slides
Practical Solutions to SSc-ILD Treatment - Slide Deck
No image set
Improved Patient Outcomes in PAH
9088-pfild-slides8
A New Paradigm in Treating ILD - Slide Deck
No image set
Principles of Management of Chronic GVHD
No image set
Diagnosing and Assessing Chronic Graft-versus-Host Disease
9101-chest
IPF Management and Antifibrotic Therapy
No image set
How to Develop an Effective Risk Reduction Strategy in Pulmonary Arterial Hypertension
No image set
Pulmonary Arterial Hypertension (PAH) - Therapy Options Explained
No image set
Updates in Duchenne Muscular Dystrophy: A Focus on Emerging Gene Therapy
No image set
EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies
No image set
EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease
No image set
Cardiac Amyloidosis: Is It A Zebra or A Horse? Webinar Summary Module
No image set
Cardiac Amyloidosis Webinar #4: Treatment of Cardiac Amyloidosis
No image set
Cardiac Amyloidosis Webinar #3: Establishing the Correct Diagnosis
No image set
Cardiac Amyloidosis Webinar #2: Cardiac Imaging Pearls
No image set
Cardiac Amyloidosis Webinar #1: Who Should I be Testing?
No image set
Updates in Diabetes Care for Primary Care Providers
No image set
Osteoporosis Updates: Primary Care’s Critical Role
No image set
Primary Care and Dyslipidemia: What Should You Do?
No image set
Staying Current in Obesity Management: Key Updates for Primary Care
No image set
Thyroid Assessment: Updates for Primary Care
No image set
A New Paradigm in Treating ILD
No image set
A Collaborative Approach to IPF Management
No image set
Practical Solutions to SSc-ILD Treatment
No image set
Post COVID-19 and Patients With and Without Pre-existing ILD
No image set
Exploring CGM: Achieving Treatment Goals Together
No image set
Reversing DOACS: Providing Answers to What, Where and How
No image set
How to Choose the Right Therapy for Your Patients with IPF
No image set
PAH: Aligning Treatment Strategy to Risk Level
No image set
PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes
No image set
LGMD: Mutation-specific Nomenclature
No image set
LGMD Symptomatology
No image set
LGMD Mutations and Disease Types
No image set
Tests and Outcomes - DMD
No image set
Genes, Exons, and the Pathophysiology of DMD
No image set
The Natural History of DMD
No image set
Reversing DOACS: Recording from Live Session held on July 18, 2021
No image set
Conquer the Clot: Addressing VTE in Your Patients with Cancer
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
Updates in SMA: Cure SMA Conference Coverage (CME/CE)
9076-0001-263x149
Healthcare Disparities in African Americans With Myeloma
No image set
New and Emerging Options for the Management of MS
Page 2 of 6

Search